Huadong Medicine (000963.SZ): Products and Partnered Products Included in the National Medical Insurance Catalog and the Commercial Insurance Innovative Drug Catalog

Zhitong Finance APP news, Huadong Medicine (000963.SZ) announced that some of the company's products and cooperative products have been included in the new version of the drug catalog and the new version of the commercial insurance innovative drug catalog. The company's wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s Mefatinib Maleate Tablets have been included in the negotiated drug section during the agreement period; the cooperative product Proline Sitagliptin Tablets have completed renewal, with payment standards and payment scope unchanged; Tacrolimus Granules have been adjusted to routine catalog management, with payment scope unchanged compared to the previous version of the drug catalog; the cooperative product Zevorcabtagene Autoleucel Injection continues to be included in the new version of the commercial insurance innovative drug catalog.